ACUTE MYELOID LEUKEMIA RECURRENT
Clinical trials for ACUTE MYELOID LEUKEMIA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA RECURRENT trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-in-Human trial tests supercharged immune cells to fight blood cancer
Disease control Recruiting nowThis is an early-stage study to test the safety of a new cell therapy for adults with acute myeloid leukemia (AML). Researchers are combining specially trained immune cells, called CIML NK cells, with a standard drug (venetoclax) to try to better control the cancer. The study wil…
Matched conditions: ACUTE MYELOID LEUKEMIA RECURRENT
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: ACUTE MYELOID LEUKEMIA RECURRENT
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC